Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8225)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Matsushita K, Shimada H, Ueda Y, Inoue M, Hasegawa M, Tomonaga T, Matsubara H, Nomura F. Non-transmissible Sendai virus vector encoding |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4316.htm |
| Number | Citing Articles |
| 1 |
Ekati Drakopoulou, Nicholas P. Anagnou, Kalliopi I. Pappa. Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story. Cancers 2022; 14(13): 3238 doi: 10.3390/cancers14133238
|
| 2 |
N Tanaka, K Araki, D Mizokami, Y Miyagawa, T Yamashita, M Tomifuji, Y Ueda, M Inoue, K Matsushita, F Nomura, H Shimada, A Shiotani. Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer. Gene Therapy 2015; 22(4): 297 doi: 10.1038/gt.2014.123
|
| 3 |
Daisuke Mizokami, Koji Araki, Nobuaki Tanaka, Hiroshi Suzuki, Masayuki Tomifuji, Taku Yamashita, Yasuji Ueda, Hideaki Shimada, Kazuyuki Matsushita, Akihiro Shiotani, Arun Rishi. Gene Therapy of c-myc Suppressor FUSE-Binding Protein-Interacting Repressor by Sendai Virus Delivery Prevents Tracheal Stenosis. PLOS ONE 2015; 10(1): e0116279 doi: 10.1371/journal.pone.0116279
|
| 4 |
Bahityar Rahmutulla, Kazuyuki Matsushita, Fumio Nomura. Alternative splicing of DNA damage response genes and gastrointestinal cancers. World Journal of Gastroenterology 2014; 20(46): 17305-17313 doi: 10.3748/wjg.v20.i46.17305
|
| 5 |
Kazuyuki Matsushita, Kouichi Kitamura, Bahityar Rahmutulla, Nobuko Tanaka, Takayuki Ishige, Mamoru Satoh, Tyuji Hoshino, Satoru Miyagi, Takeshi Mori, Sakae Itoga, Hideaki Shimada, Takeshi Tomonaga, Minoru Kito, Yaeko Nakajima-Takagi, Shuji Kubo, Chiaki Nakaseko, Masahiko Hatano, Takashi Miki, Masafumi Matsuo, Masaki Fukuyo, Atsushi Kaneda, Atsushi Iwama, Fumio Nomura. Haploinsufficiency of thec-myctranscriptional repressorFIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1. Oncotarget 2015; 6(7): 5102 doi: 10.18632/oncotarget.3244
|
| 6 |
Caiqi Ma, Zhijian Huang, Zhikun Wu, Chunguang Di, Xueping Lin, Mao Huang, Honghai Hong, Haofan Yin. Overexpression of FUBP1 is associated with human cervical carcinoma development and prognosis. Life Sciences 2021; 269: 119098 doi: 10.1016/j.lfs.2021.119098
|
| 7 |
Assaf Magen, Avinash Das, Joo Sang Lee, Mahfuza Sharmin, Alexander Lugo, J. Silvio Gutkind, Alejandro A. Schäffer, Eytan Ruppin, Sridhar Hannenhalli. Beyond Synthetic Lethality: Charting the Landscape of Clinically Relevant Genetic Interactions in Cancer. SSRN Electronic Journal 2019; doi: 10.2139/ssrn.3329251
|
| 8 |
M Kano, K Matsushita, B Rahmutulla, S Yamada, H Shimada, S Kubo, T Hiwasa, H Matsubara, F Nomura. Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams. Gene Therapy 2016; 23(1): 50 doi: 10.1038/gt.2015.84
|
| 9 |
Assaf Magen, Avinash Das Sahu, Joo Sang Lee, Mahfuza Sharmin, Alexander Lugo, J. Silvio Gutkind, Alejandro A. Schäffer, Eytan Ruppin, Sridhar Hannenhalli. Beyond Synthetic Lethality: Charting the Landscape of Pairwise Gene Expression States Associated with Survival in Cancer. Cell Reports 2019; 28(4): 938 doi: 10.1016/j.celrep.2019.06.067
|
| 10 |
Ángela Áyen, Yaiza Jiménez Martínez, Houria Boulaiz. Targeted Gene Delivery Therapies for Cervical Cancer. Cancers 2020; 12(5): 1301 doi: 10.3390/cancers12051301
|